195 related articles for article (PubMed ID: 31709534)
1. Decreased levels of constitutive proteasomes in experimental autoimmune encephalomyelitis may be caused by a combination of subunit displacement and reduced Nfe2l1 expression.
Shanley KL; Hu CL; Bizzozero OA
J Neurochem; 2020 Mar; 152(5):585-601. PubMed ID: 31709534
[TBL] [Abstract][Full Text] [Related]
2. Proteasome Composition in Cytokine-Treated Neurons and Astrocytes is Determined Mainly by Subunit Displacement.
Shanley KL; Hu CL; Bizzozero OA
Neurochem Res; 2020 Apr; 45(4):860-871. PubMed ID: 31939090
[TBL] [Abstract][Full Text] [Related]
3. Changes in 20S subunit composition are largely responsible for altered proteasomal activities in experimental autoimmune encephalomyelitis.
Zheng J; Dasgupta A; Bizzozero OA
J Neurochem; 2012 May; 121(3):486-94. PubMed ID: 22353035
[TBL] [Abstract][Full Text] [Related]
4. The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
Smith BC; Sinyuk M; Jenkins JE; Psenicka MW; Williams JL
J Neuroinflammation; 2020 Jun; 17(1):184. PubMed ID: 32532298
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.
Belogurov A; Kuzina E; Kudriaeva A; Kononikhin A; Kovalchuk S; Surina Y; Smirnov I; Lomakin Y; Bacheva A; Stepanov A; Karpova Y; Lyupina Y; Kharybin O; Melamed D; Ponomarenko N; Sharova N; Nikolaev E; Gabibov A
FASEB J; 2015 May; 29(5):1901-13. PubMed ID: 25634956
[TBL] [Abstract][Full Text] [Related]
6. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
7. Proteomic identification of immunoproteasome accumulation in formalin-fixed rodent spinal cords with experimental autoimmune encephalomyelitis.
Jain MR; Li Q; Liu T; Rinaggio J; Ketkar A; Tournier V; Madura K; Elkabes S; Li H
J Proteome Res; 2012 Mar; 11(3):1791-803. PubMed ID: 22188123
[TBL] [Abstract][Full Text] [Related]
8. Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Morales Pantoja IE; Hu CL; Perrone-Bizzozero NI; Zheng J; Bizzozero OA
J Neurochem; 2016 Nov; 139(4):640-650. PubMed ID: 27579494
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
10. Reduced proteasomal activity contributes to the accumulation of carbonylated proteins in chronic experimental autoimmune encephalomyelitis.
Zheng J; Bizzozero OA
J Neurochem; 2010 Dec; 115(6):1556-67. PubMed ID: 20950414
[TBL] [Abstract][Full Text] [Related]
11. Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.
Feng M; Shu Y; Yang Y; Zheng X; Li R; Wang Y; Dai Y; Qiu W; Lu Z; Hu X
Neurochem Int; 2014 Jan; 64():64-72. PubMed ID: 24274996
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of Krüppel-like factor 4 in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Ahn M; Kim J; Park C; Jung K; Moon C; Shin T
Acta Histochem; 2015 Jul; 117(6):521-7. PubMed ID: 25944743
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical studies on disabled-2 protein in the spinal cords of rats with experimental autoimmune encephalomyelitis.
Ahn M; Oh H; Lee W; Kim H; Moon C; Shin T
Brain Res; 2011 Oct; 1416():51-60. PubMed ID: 21890121
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological inhibition of soluble epoxide hydrolase attenuates chronic experimental autoimmune encephalomyelitis by modulating inflammatory and anti-inflammatory pathways in an inflammasome-dependent and -independent manner.
Biliktu M; Senol SP; Temiz-Resitoglu M; Guden DS; Horat MF; Sahan-Firat S; Sevim S; Tunctan B
Inflammopharmacology; 2020 Dec; 28(6):1509-1524. PubMed ID: 32128702
[TBL] [Abstract][Full Text] [Related]
15. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines.
Puttaparthi K; Elliott JL
Exp Neurol; 2005 Dec; 196(2):441-51. PubMed ID: 16242125
[TBL] [Abstract][Full Text] [Related]
16. The role of fatty acid binding protein 7 in spinal cord astrocytes in a mouse model of experimental autoimmune encephalomyelitis.
Kamizato K; Sato S; Shil SK; Umaru BA; Kagawa Y; Yamamoto Y; Ogata M; Yasumoto Y; Okuyama Y; Ishii N; Owada Y; Miyazaki H
Neuroscience; 2019 Jun; 409():120-129. PubMed ID: 31051217
[TBL] [Abstract][Full Text] [Related]
17. Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation.
Guillot F; Garcia A; Salou M; Brouard S; Laplaud DA; Nicot AB
J Neuroinflammation; 2015 Jul; 12():130. PubMed ID: 26141738
[TBL] [Abstract][Full Text] [Related]
18. Progesterone down-regulates spinal cord inflammatory mediators and increases myelination in experimental autoimmune encephalomyelitis.
Garay LI; González Deniselle MC; Brocca ME; Lima A; Roig P; De Nicola AF
Neuroscience; 2012 Dec; 226():40-50. PubMed ID: 23000619
[TBL] [Abstract][Full Text] [Related]
19. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
20. Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.
Emami Aleagha MS; Harirchian MH; Lavasani S; Javan M; Allameh A
J Mol Neurosci; 2018 Apr; 64(4):543-550. PubMed ID: 29542092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
